Essay On Genome Sequencing

1094 Words5 Pages
Description Every state within the United States runs its own newborn screening program which test for at least 30 serious conditions which are treatable if caught early. The program is designed to save lives and uses the dried blood sample collected during the first week after birth. The blood sample is used to measure the presence of disease markers. The current newborn screening programs are fast, cost effective, and accurate in identifying disease before symptoms appear. Genome sequencing cost have now decrease to a price range like other complex medical test to be readily available for clinical application. It is possible for genome sequencing to replace or supplement the existing traditional panels for newborn screening tests. The…show more content…
The participants will only be enrolled after participating in an informed consent process. The participants have a choice on whether they want to receive the information or not. The focus of the study is to determine how clinicians and families use the genomic sequence results in their decision making. If a family wishes not to know their sequence information they do not have to participant. The technological advances in DNA sequencing have made high throughout sequencing methods faster and cheaper. In contrast this allows researchers to generate larger datasets to be used for genome wide association studies to identify specific factors associated with human health and disease. Specification The National Institutes of Health in 2008 implemented a genome wide association studies policy to require the data from National Institutes of Health funded studies to share collected data with the research community to maintain the Genotypes and Phenotypes database. The participants privacy is protected through a controlled access policy with a requires secondary use of data to be consist with the initial informed consent given. For future usage the research must obtain another consent for the participants data to be used for future research expand the database. For example, the HeLa Genome Data Use Agreement in August 2013 detailed the importance of controlling data access to protect research participant privacy. The HeLa
Get Access